HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
M Hahka-Kemppinen Selected Research
M Hahka-Kemppinen Research Topics
Disease
7
Melanoma (Melanoma, Malignant)
09/2001 - 01/2000
4
Neoplasm Metastasis (Metastasis)
09/2001 - 06/2000
4
Neoplasms (Cancer)
08/2000 - 06/2000
1
Breast Neoplasms (Breast Cancer)
05/2010
1
Uveal melanoma
05/2003
1
Disease Progression
01/2000
Drug/Important Bio-Agent (IBA)
1
Docetaxel (Taxotere)
FDA Link
05/2010
1
Gemcitabine
FDA Link
05/2010
1
Vincristine (Oncovin)
FDA Link
Generic
05/2003
1
Interferon alpha-2 (Roferon-A)
FDA Link
05/2003
1
Bleomycin (Blenoxane)
FDA Link
Generic
05/2003
1
Dacarbazine (DIC)
FDA Link
Generic
05/2003
1
Interferons
IBA
05/2003
1
Lomustine (CCNU)
FDA Link
05/2003
1
Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)
IBA
09/2001
1
Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)
IBA
09/2001
1
Interleukin-2 Receptors (IL 2 Receptor)
IBA
09/2001
1
collagenase 1
IBA
04/2001
1
Peptide Hydrolases (Proteases)
FDA Link
04/2001
1
Matrix Metalloproteinases (MMPs)
IBA
04/2001
1
Proteins (Proteins, Gene)
FDA Link
08/2000
1
Interleukin-10 (Interleukin 10)
IBA
06/2000
1
Interleukin-12 (IL 12)
IBA
06/2000
1
Interleukins
IBA
06/2000
1
Interleukin-6 (Interleukin 6)
IBA
06/2000
1
Integrin beta1
IBA
06/2000
1
S100 Calcium Binding Protein beta Subunit
IBA
06/2000
1
Integrins
IBA
06/2000
1
Matrix Metalloproteinase 2 (Gelatinase A)
IBA
01/2000
Therapy/Procedure
2
Drug Therapy (Chemotherapy)
05/2010 - 05/2003
1
Time-to-Treatment
05/2010
1
Aftercare (After-Treatment)
08/2000
1
Conservative Treatment
08/2000